Reduced monocyte and macrophage TNFSF15/TL1A expression is associated with susceptibility to inflammatory bowel disease
暂无分享,去创建一个
Kenneth G. C. Smith | James C. Lee | Arianne C. Richard | P. Lyons | J. Peters | R. Siegel | N. Savinykh | Eric T Hawley | F. Meylan | E. Hawley
[1] David Haussler,et al. The UCSC Genome Browser database: 2018 update , 2017, Nucleic Acids Res..
[2] Nicola J. Rinaldi,et al. Genetic effects on gene expression across human tissues , 2017, Nature.
[3] Hailiang Huang,et al. Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.
[4] Geoffrey J Faulkner,et al. Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease , 2017, PLoS genetics.
[5] L. Mattheakis. Faculty Opinions recommendation of IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking. , 2017 .
[6] Zachary A. Szpiech,et al. Genetic Ancestry and Natural Selection Drive Population Differences in Immune Responses to Pathogens , 2016, Cell.
[7] Jianjun Liu,et al. Fine-mapping analysis revealed complex pleiotropic effect and tissue-specific regulatory mechanism of TNFSF15 in primary biliary cholangitis, Crohn’s disease and leprosy , 2016, Scientific Reports.
[8] Kenneth G. C. Smith,et al. Targeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network , 2016, Genome Medicine.
[9] L. Burkly,et al. A Novel Role for TL1A/DR3 in Protection against Intestinal Injury and Infection , 2016, The Journal of Immunology.
[10] Kenneth G. C. Smith,et al. Insight into Genotype-Phenotype Associations through eQTL Mapping in Multiple Cell Types in Health and Immune-Mediated Disease , 2016, PLoS Genetics.
[11] J. Rioux,et al. IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking* , 2016, The Journal of Biological Chemistry.
[12] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[13] Arianne C. Richard,et al. The TNF‐family cytokine TL1A: from lymphocyte costimulator to disease co‐conspirator , 2015, Journal of leukocyte biology.
[14] D. Heo,et al. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL‐22 production and IL‐2‐dependent proliferation , 2015, European journal of immunology.
[15] Judy H. Cho,et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.
[16] D. Littman,et al. The functional impact of the intestinal microbiome on mucosal immunity and systemic autoimmunity , 2015, Current opinion in rheumatology.
[17] G. Kempermann. Faculty Opinions recommendation of Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. , 2015 .
[18] Jun S. Liu,et al. The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans , 2015, Science.
[19] Arianne C. Richard,et al. The TNF-Family Ligand TL1A and Its Receptor DR3 Promote T Cell–Mediated Allergic Immunopathology by Enhancing Differentiation and Pathogenicity of IL-9–Producing T Cells , 2015, The Journal of Immunology.
[20] Thomas J. Ha,et al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells , 2015, Science.
[21] N. Warner,et al. NOD1 and NOD2: signaling, host defense, and inflammatory disease. , 2014, Immunity.
[22] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[23] C. Abraham,et al. A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8–induced IL-1 , 2014, Proceedings of the National Academy of Sciences.
[24] F. Geissmann,et al. Constant replenishment from circulating monocytes maintains the macrophage pool in adult intestine , 2014, Nature Immunology.
[25] Emily R. Miraldi,et al. CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22 , 2014, The Journal of experimental medicine.
[26] C. Bain,et al. Macrophages in intestinal homeostasis and inflammation , 2014, Immunological reviews.
[27] Jacob D. Jaffe,et al. Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense , 2014, Proceedings of the National Academy of Sciences.
[28] Daphne Koller,et al. Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.
[29] K. McCoy,et al. The interplay between the gut microbiota and the immune system , 2014, Gut microbes.
[30] R. Andrews,et al. Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression , 2014, Science.
[31] Manolis Kellis,et al. Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells , 2014, Science.
[32] J. DeVoss,et al. A Crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3 , 2014, Nature.
[33] X. Chen,et al. The TNF-Family Cytokine TL1A Promotes Allergic Immunopathology through Group 2 Innate Lymphoid Cells , 2013, Mucosal Immunology.
[34] B. Xia,et al. High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease , 2013, Mediators of inflammation.
[35] Xuehai Wang,et al. TNF-like Ligand 1A (TL1A) Gene Knockout Leads to Ameliorated Collagen-Induced Arthritis in Mice: Implication of TL1A in Humoral Immune Responses , 2013, The Journal of Immunology.
[36] D. Yan,et al. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers , 2013, Mucosal Immunology.
[37] A. Kaser,et al. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation , 2013, Gut.
[38] M. Peters,et al. Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.
[39] C. Wallace,et al. Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics , 2013, PLoS genetics.
[40] Todd A. Johnson,et al. A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population. , 2013, Gastroenterology.
[41] N. Beaucamp,et al. TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFα, from CD3+CD161+ T cells to exacerbate gut inflammation , 2012, Mucosal Immunology.
[42] David Haussler,et al. ENCODE Data in the UCSC Genome Browser: year 5 update , 2012, Nucleic Acids Res..
[43] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[44] Jennifer Mulle,et al. A Genome-Wide Scan of Ashkenazi Jewish Crohn's Disease Suggests Novel Susceptibility Loci , 2012, PLoS genetics.
[45] F. Vannberg,et al. GENETICS OF GENE EXPRESSION IN PRIMARY IMMUNE CELLS IDENTIFIES CELL-SPECIFIC MASTER REGULATORS AND ROLES OF HLA ALLELES , 2012, Nature Genetics.
[46] W. Ouyang,et al. Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice , 2011, Mucosal Immunology.
[47] L. Honigberg,et al. Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q , 2011, PloS one.
[48] T. Ślebioda,et al. Triggering of TNFRSF25 promotes CD8+ T‐cell responses and anti‐tumor immunity , 2011, European journal of immunology.
[49] Y. Okada,et al. HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease. , 2011, Gastroenterology.
[50] Gonçalo R. Abecasis,et al. The variant call format and VCFtools , 2011, Bioinform..
[51] A. Zinsmeister,et al. Association of TNFSF15 polymorphism with irritable bowel syndrome , 2011, Gut.
[52] C. Abraham,et al. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses , 2011, Proceedings of the National Academy of Sciences.
[53] R. Desnick,et al. Evaluation of 22 genetic variants with Crohn's Disease risk in the Ashkenazi Jewish population: a case-control study , 2011, BMC Medical Genetics.
[54] K. Peris,et al. The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans , 2011, PloS one.
[55] S. Ladas,et al. High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. , 2010, Clinical immunology.
[56] R. Siegel,et al. The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation , 2010, Mucosal Immunology.
[57] Rafael A. Irizarry,et al. A framework for oligonucleotide microarray preprocessing , 2010, Bioinform..
[58] Silke Szymczak,et al. Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility , 2010, PloS one.
[59] Leopold Parts,et al. A Bayesian Framework to Account for Complex Non-Genetic Factors in Gene Expression Levels Greatly Increases Power in eQTL Studies , 2010, PLoS Comput. Biol..
[60] S. Targan,et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells , 2009, European journal of immunology.
[61] F. Ginhoux,et al. Origin of the lamina propria dendritic cell network. , 2009, Immunity.
[62] Steffen Jung,et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. , 2009, Immunity.
[63] Robert Gentleman,et al. Data structures and algorithms for analysis of genetics of gene expression with Bioconductor: GGtools 3.x , 2009, Bioinform..
[64] T. Shimosegawa,et al. TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells. , 2009, Human molecular genetics.
[65] S. Targan,et al. IBD-Associated TL1A Gene (TNFSF15) Haplotypes Determine Increased Expression of TL1A Protein , 2009, PloS one.
[66] A. Murphy,et al. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.
[67] Sarah L. Brown,et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells , 2008, Nature.
[68] T. Ślebioda,et al. The Death Receptor 3–TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis , 2008, The Journal of experimental medicine.
[69] S. Targan,et al. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. , 2008, Gastroenterology.
[70] E. Shevach,et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. , 2008, Immunity.
[71] M. Scott,et al. TL1A–DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease , 2008, The Journal of experimental medicine.
[72] E. Podack,et al. Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation , 2008, The Journal of experimental medicine.
[73] S. Sa,et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.
[74] S. Targan,et al. The T Cell Costimulator TL1A Is Induced by FcγR Signaling in Human Monocytes and Dendritic Cells , 2007, The Journal of Immunology.
[75] J. Ragoussis,et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. , 2005, Human molecular genetics.
[76] M Schwab,et al. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.
[77] S. Targan,et al. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation. , 2004, Clinical immunology.
[78] S. Targan,et al. TL1A Synergizes with IL-12 and IL-18 to Enhance IFN-γ Production in Human T Cells and NK Cells1 , 2004, The Journal of Immunology.
[79] P. Wei,et al. Expression, Localization, and Functional Activity of TL1A, a Novel Th1-Polarizing Cytokine in Inflammatory Bowel Disease 1 , 2003, The Journal of Immunology.
[80] J. Hugot,et al. Gene–environment interaction modulated by allelic heterogeneity in inflammatory diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[81] Jun Zhang,et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. , 2002, Immunity.
[82] Judy H. Cho,et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.
[83] Florian Hahne,et al. Visualizing Genomic Data Using Gviz and Bioconductor , 2016, Statistical Genomics.
[84] G. Daikos,et al. Differential expression of the TL1A/DcR3 system of TNF/TNFR-like proteins in large vs. small intestinal Crohn's disease. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[85] D. Jewell,et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation , 2010, Nature Medicine.
[86] S. Targan,et al. TL1A synergizes with IL-12 and IL-18 to enhance IFN-gamma production in human T cells and NK cells. , 2004, Journal of immunology.